TITLE:
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

CONDITION:
Diabetes Mellitus

INTERVENTION:
Lantus (insulin glargine [rDNA origin] injection)

SUMMARY:

      The purposes of the study is to determine whether blood sugar control is different between
      Lantus and a third oral anti-diabetic agent when added to patients who fail a
      thiazolidinedione and sulfonylurea or metformin combination.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 79 Years
Criteria:

        Inclusion Criteria:

          -  Patients between 18 - 79 years of age

          -  With diagnosed type 2 diabetes for at least a year treated with stable doses of two
             oral antidiabetic drugs of which one is either Avandia or Actos for at least three
             months

        Exclusion Criteria:

          -  Major cardiovascular events

        The above information is not intended to contain all considerations relevant to a
        patient's potential participation in a clinical trial.
      
